MENU
+Compare
FFTY
ETF ticker: NYSE
AS OF
Jul 25 closing price
Price
$33.90
Change
+$0.43 (+1.28%)
Net Assets
83.03M

FFTY stock forecast, quote, news & analysis

The investment seeks to track, before fees and expenses, the performance of the IBD® 50 Index (the "index")... Show more

Category: #Mid-Cap Growth
FFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for FFTY with price predictions
Jul 25, 2025

Aroon Indicator for FFTY shows an upward move is likely

FFTY's Aroon Indicator triggered a bullish signal on July 25, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 272 similar instances where the Aroon Indicator showed a similar pattern. In of the 272 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 16, 2025. You may want to consider a long position or call options on FFTY as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FFTY just turned positive on July 17, 2025. Looking at past instances where FFTY's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for FFTY moved above the 200-day moving average on June 20, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FFTY advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for FFTY moved out of overbought territory on June 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FFTY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FFTY broke above its upper Bollinger Band on June 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), PDD Holdings (NASDAQ:PDD), Wheaton Precious Metals Corp (NYSE:WPM), Gold Fields Ltd (NYSE:GFI), Exelixis (NASDAQ:EXEL), Guardant Health (NASDAQ:GH).

Industry description

The investment seeks to track, before fees and expenses, the performance of the IBD® 50 Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® ("IBD" or the "index provider") that seeks to identify the current top 50 growth stocks.

Market Cap

The average market capitalization across the Innovator IBD® 50 ETF ETF is 94.12B. The market cap for tickers in the group ranges from 237.87M to 208.98B. AZN holds the highest valuation in this group at 208.98B. The lowest valued company is WGS at 237.87M.

High and low price notable news

The average weekly price growth across all stocks in the Innovator IBD® 50 ETF ETF was 1%. For the same ETF, the average monthly price growth was 9%, and the average quarterly price growth was 9%. ZLAB experienced the highest price growth at 11%, while ALKS experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Innovator IBD® 50 ETF ETF was -9%. For the same stocks of the ETF, the average monthly volume growth was -33% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 72
P/E Growth Rating: 58
Price Growth Rating: 46
SMR Rating: 57
Profit Risk Rating: 49
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
FFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapGrowth

Profile
Fundamentals
Details
Category
Mid-Cap Growth
Address
Academy Funds Trust123 South Broad Street, Suite 1630Philadelphia
Phone
(215) 979-3750
Web
www.innovatorfunds.com